- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 04.04. | Memel Biotech Launches Advanced Therapy Development & Manufacturing Service | ||
| 04.04. | Pluristyx Launches PluriFreeze Cryopreservation Media | ||
| 04.04. | Rare Cancer Research Foundation Partners with Spanios to Advance Cancer Research | ||
| 04.04. | Pierre Fabre Appoints Adriana Herrera CEO of New U.S. Affiliate | ||
| 04.04. | Basilea's Antibiotic ZEVTERA Approved for Three Indications | ||
| 04.04. | Caris Partners with Merck KGaA, Darmstadt, Germany | ||
| 04.04. | Acumen Pharmaceuticals Signs Collaboration Agreement with Lonza | ||
| 04.04. | Teva and mAbxience Enter Strategic Licensing Agreement for Biosimilar Candidate | ||
| 04.04. | Ship of Theseus Taps Charles River as Manufacturing Partner | ||
| 03.04. | Neurosterix Launches with $63M Series A Financing | ||
| 03.04. | Kintara Therapeutics and TuHURA Biosciences to Merge | ||
| 03.04. | Prozomix, Ginkgo Bioworks Partner to Build Out Production of Next-Gen Enzyme Plates | ||
| 03.04. | CytomX Achieves $5M Astellas Milestone | ||
| 03.04. | Genmab to Acquire ProfoundBio for $1.8B | ||
| 03.04. | Fanapt Approved by FDA for Treatment of Bipolar I Disorder | ||
| 03.04. | Autolomous and BioCentriq Partner to Transform Operations | ||
| 03.04. | Experic Appoints Philip Dunne as Director of EU Operations | ||
| 03.04. | Invenra & Catalent Team Up to Develop Next-Gen Cancer Therapies | ||
| 02.04. | Kemwell BioPharma Implements Veeva QMS | ||
| 02.04. | Ginkgo Bioworks Acquires Modulus Cell Therapy Platform Assets | ||
| 02.04. | Gilead, Nurix Therapeutics Extend Strategic Research Pact | ||
| 02.04. | Trevi Therapeutics Welcomes Margaret Garin as VP of Clinical Development | ||
| 02.04. | Lonza Appoints Wolfgang Wienand CEO | ||
| 02.04. | Bespak Separates Recipharm's Advanced Delivery Systems Business Unit to Form Standalone Company | ||
| 02.04. | Delpharm Acquires Astellas' Meppel Solid Dosage Production Facilities |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
